Debates & Insight Sponsored Brexit - What now for pharma? Join us for a one-hour live webinar entitled Brexit - What now for pharma?
Debates & Insight Sponsored Available on demand: Cancer Treatment Access: Strategy, Appr... Available on demand: A one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes.
Debates & Insight Sponsored Available on demand: What will changes to England's pharmacy... New measures proposed by the Government will impact community pharmacies across the UK.
Debates & Insight Sponsored Available on demand: What's next for patient-centricity? This webinar delved into the challenges that pharma face when looking at their patient-centricity strategy.
Debates & Insight Sponsored Pricing & Market Access Outlook 2015/2016 Edition Pricing and market access (P&MA) are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet need
News NHS to offer Wegovy to a million more people in England The NHS in England will make Novo Nordisk's Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
